Eudaimonia Partners, LLC Amgen Inc Transaction History

Eudaimonia Partners, LLC

$416 Million
Q1 2024

A detailed history of Eudaimonia Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Eudaimonia Partners, LLC holds 773 shares of AMGN stock, worth $216,447. This represents 0.05% of its overall portfolio holdings.

Number of Shares

773

Previous 773 -0.0%

Holding current value

$216,447

Previous $222,000 1.35%

% of portfolio

0.05%

Previous 0.06%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$255.7 - $288.46 $596,548 - $672,977	-2,333 Reduced 75.11%	773 $222,000
Q3 2023 Oct 24, 2023	SELL	$218.65 - $271.46 $2,623 - $3,257	-12 Reduced 0.38%	3,106 $834,000
Q2 2023 Jul 19, 2023	BUY	$214.27 - $253.37 $263,980 - $312,151	1,232 Added 65.32%	3,118 $692,000
Q1 2023 Apr 25, 2023	BUY	$225.79 - $275.2 $164,375 - $200,345	728 Added 62.87%	1,886 $455,000
Q4 2022 Jan 24, 2023	SELL	$229.03 - $291.01 $25,651 - $32,593	-112 Reduced 8.82%	1,158 $0
Q3 2022 Nov 03, 2022	SELL	$224.46 - $253.15 $66,215 - $74,679	-295 Reduced 18.85%	1,270 $286,000
Q2 2022 Aug 09, 2022	BUY	$230.71 - $256.74 $16,380 - $18,228	71 Added 4.75%	1,565 $381,000
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $17,980 - $19,890	-82 Reduced 5.2%	1,494 $361,000
Q3 2021 Oct 25, 2021	SELL	$212.27 - $248.7 $23,137 - $27,108	-109 Reduced 6.47%	1,576 $335,000
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $7,007 - $7,774	-30 Reduced 1.75%	1,685 $411,000
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $11,095 - $12,930	-50 Reduced 2.83%	1,715 $427,000
Q4 2020 Feb 18, 2021	BUY	$216.38 - $257.67 $2,380 - $2,834	11 Added 0.63%	1,765 $405,000
Q3 2020 Nov 23, 2020	SELL	$234.65 - $260.95 $15,956 - $17,744	-68 Reduced 3.73%	1,754 $446,000
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $76,261 - $84,808	325 Added 21.71%	1,822 $149,000
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $3,758 - $4,612	19 Added 1.29%	1,497 $353,000
Q1 2020 May 05, 2020	BUY	$182.24 - $241.7 $20,410 - $27,070	112 Added 8.2%	1,478 $300,000
Q4 2019 May 05, 2020	BUY	$189.21 - $243.2 $258,460 - $332,211	1,366 New	1,366 $329,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eudaimonia Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eudaimonia Partners, LLC with notifications on news.

Account

Eudaimonia Partners, LLC Amgen Inc Transaction History